Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting a website/UI release rather than a modification to the study record content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check74 days agoChange Detected- Revision label updated from v3.4.1 to v3.4.2 on the page. This is a minor frontend/version change that does not affect study details or eligibility criteria.SummaryDifference0.1%

- Check81 days agoChange DetectedSite updated to Revision v3.4.1. The study page content and functionality remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check102 days agoChange DetectedThe only visible change is the updated revision tag: Revision: v3.3.4 replacing the previous Revision: v3.3.3 on the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.